$24.76
+0.92 (+3.86%)
Performance
1D
—
1W
—
1M
—
3M
-5.35%
6M
+54.17%
1Y
+38.40%
YTD
-4.44%
Open$24.28
Previous Close$23.84
Day High$25.17
Day Low$24.26
52W High$27.92
52W Low$12.72
Volume—
Avg Volume1.56M
Market Cap5.37B
P/E Ratio—
EPS$-2.68
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.99
Below
SMA 200
$19.59
Above
RSI (14)
49.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+146.1% upside
Current
$24.76
$24.76
Target
$60.94
$60.94
$43.15
$60.94 avg
$94.48
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.40B | 1.44B | 1.30B |
| Net Income | 261.90M | 339.04M | 251.92M |
| Profit Margin | 18.7% | 23.6% | 19.4% |
| EBITDA | 403.28M | 390.65M | 352.93M |
| Free Cash Flow | 259.22M | 284.01M | 237.35M |
| Rev Growth | +1.7% | -7.0% | +15.8% |
| Debt/Equity | 0.75 | 0.69 | 0.65 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |